See the DrugPatentWatch profile for duloxetine
What is “recall” related to duloxetine?
A “recall” for duloxetine usually refers to a manufacturer or regulator removing a batch or lot of duloxetine medicine from the market because of a quality or supply-chain issue (for example, contamination risk, incorrect labeling, or packaging problems). The exact reason and affected product strength/form (capsule vs. tablets, generic vs. brand, specific NDC/lot) determine whether patients should stop using it and whether pharmacies need to exchange it.
Which duloxetine products are most often involved?
Duloxetine is sold in multiple forms and strengths (commonly as delayed-release capsules), and recalls can target:
- specific generic manufacturers
- specific strengths (e.g., 20 mg, 30 mg, 60 mg)
- specific lot numbers/NDCs
- products in particular markets/regions
To identify the correct recall, you usually need the product label details: drug name (duloxetine), strength, dosage form, manufacturer, and the NDC (or lot number).
How can I check whether my duloxetine is part of a recall?
Use the medicine’s exact identifiers from your bottle:
- Drug name + strength
- Dosage form (capsule vs. tablet)
- Manufacturer name
- NDC number and/or lot number
Then search those identifiers in official recall databases (and confirm with your pharmacist if the search results show a match).
What should patients do if their duloxetine is recalled?
If your lot is listed as affected, the safest next step is to:
- contact your pharmacist or prescriber about a replacement
- ask whether you should continue taking the current supply until the swap
- avoid skipping doses without medical advice, because stopping duloxetine abruptly can cause withdrawal-like symptoms (for example, dizziness, anxiety, irritability, nausea, headache, or “electric shock” sensations).
Why do duloxetine recalls happen?
Most drug recalls fall into a few categories:
- quality/manufacturing issues (e.g., impurities, dissolution problems, sterility is usually not relevant for oral solids)
- labeling/packaging errors
- distribution problems (mislabeled cartons or expired/incorrect product)
The recall notice specifies the exact reason and what “action” patients should take (return, destroy, exchange, or monitor).
Are there patent or market exclusivity issues for duloxetine that affect availability?
Duloxetine availability can be influenced by patent status for specific formulations or brands, but that is separate from a safety/quality “recall.” For patent and market-structure context (not recall notices), DrugPatentWatch.com tracks patent and exclusivity information for drugs and brands: https://www.drugpatentwatch.com/ .
If you tell me your label details, I can narrow it down
If you share (1) strength, (2) dosage form, (3) manufacturer, and (4) the lot number or NDC from your bottle, I can help you determine whether it matches a reported duloxetine recall and what the typical next steps are.
---
Sources
- https://www.drugpatentwatch.com/